Kytopen Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Series B
- Investors
-
16
Kytopen General Information
Description
Developer of a cell engineering platform designed to offer healthy and functional cells. The company's tool uses a fast, scalable, and gentle process that yields quality engineered cells in minutes while maintaining cell health and function, enabling researchers to combine continuous fluid flow with electric fields for efficient delivery of payloads to primary cells.
Contact Information
Website
www.kytopen.comCorporate Office
- 750 Main Street
- Cambridge, MA 02139-4018
- United States
Corporate Office
- 750 Main Street
- Cambridge, MA 02139-4018
- United States
Kytopen Timeline
Kytopen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series B) | 07-Apr-2026 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series AA) | 20-Feb-2025 | Completed | Generating Revenue | |||
| 9. Seed Round | 26-Sep-2024 | Completed | Generating Revenue | |||
| 8. Early Stage VC (Series A) | 27-Sep-2021 | Completed | Generating Revenue | |||
| 7. Grant | 20-Apr-2021 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series 3) | 06-Nov-2020 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 13-Apr-2020 | Completed | Generating Revenue | |||
| 4. Grant | 01-Dec-2019 | Completed | Generating Revenue | |||
| 3. Seed Round | 23-May-2019 | $4.35M | $4.35M | Completed | Generating Revenue | |
| 2. Grant | 01-Mar-2019 | $1.17M | Completed | Generating Revenue |
Kytopen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Senior Seed-3 | ||||||||
| Senior Seed-2 | ||||||||
| Senior Seed-1 | ||||||||
| Senior A | ||||||||
| Series A | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 1,312,500 | $0.000100 | $0.57 | $0.57 | $0.57 | 3.52% | ||
| Seed-1 | 3,600,000 | $0.000100 | $1 | $1 | $1 | 9.64% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Kytopen Comparisons
Industry
Financing
Details
Kytopen Competitors (14)
One of Kytopen’s 14 competitors is Scipher Medicine, a Venture Capital-Backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Scipher Medicine | Venture Capital-Backed | Waltham, MA | ||||
| BioLegend | Formerly Accelerator/Incubator backed | San Diego, CA | ||||
| CIS Bio International | Formerly PE-Backed | Saclay, France | ||||
| Encellin | Venture Capital-Backed | Pleasanton, CA | ||||
| Menarini Silicon Biosystems | Formerly VC-backed | Castel Maggiore, Italy |
Kytopen Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kytopen Patents
Kytopen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024220694-A2 | System, devices and protocols for automated transfection | Inactive | 19-Apr-2023 | ||
| WO-2024220694-A3 | System, devices and protocols for automated transfection | Inactive | 19-Apr-2023 | ||
| AU-2022264336-A1 | Methods for electro-mechanical transfection | Inactive | 27-Apr-2021 | ||
| CA-3216764-A1 | Methods for electro-mechanical transfection | Pending | 27-Apr-2021 | ||
| EP-4330387-A1 | Methods for electro-mechanical transfection | Pending | 27-Apr-2021 | C12M35/02 |
Kytopen Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kytopen Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Telegraph Hill Partners | Venture Capital | Minority | ||
| Bantam Group | Angel Group | Minority | ||
| Northpond Ventures | Venture Capital | Minority | ||
| Selvedge Venture | Venture Capital | Minority | ||
| TBD Angels | Angel Group | Minority |
Kytopen FAQs
-
When was Kytopen founded?
Kytopen was founded in 2017.
-
Where is Kytopen headquartered?
Kytopen is headquartered in Cambridge, MA.
-
What is the size of Kytopen?
Kytopen has 26 total employees.
-
What industry is Kytopen in?
Kytopen’s primary industry is Discovery Tools (Healthcare).
-
Is Kytopen a private or public company?
Kytopen is a Private company.
-
What is Kytopen’s current revenue?
The current revenue for Kytopen is .
-
How much funding has Kytopen raised over time?
Kytopen has raised $52.9M.
-
Who are Kytopen’s investors?
Telegraph Hill Partners, Bantam Group, Northpond Ventures, Selvedge Venture, and TBD Angels are 5 of 16 investors who have invested in Kytopen.
-
Who are Kytopen’s competitors?
Scipher Medicine, BioLegend, CIS Bio International, Encellin, and Menarini Silicon Biosystems are some of the 14 competitors of Kytopen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
